These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22980396)

  • 41. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery.
    Tritapepe L; De Santis V; Vitale D; Guarracino F; Pellegrini F; Pietropaoli P; Singer M
    Br J Anaesth; 2009 Feb; 102(2):198-204. PubMed ID: 19151048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early experience with Levosimendan in children with ventricular dysfunction.
    Namachivayam P; Crossland DS; Butt WW; Shekerdemian LS
    Pediatr Crit Care Med; 2006 Sep; 7(5):445-8. PubMed ID: 16885788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The novelty in the treatment of heart failure].
    Reingardiene D
    Medicina (Kaunas); 2005; 41(7):625-31. PubMed ID: 16062032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative levosimendan in ischemic mitral valve repair.
    Sharma P; Malhotra A; Gandhi S; Garg P; Bishnoi A; Gandhi H
    Asian Cardiovasc Thorac Ann; 2014 Jun; 22(5):539-45. PubMed ID: 24867027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prophylactic preoperative levosimendan administration in heart failure patients undergoing elective non-cardiac surgery: a preliminary report.
    Katsaragakis S; Kapralou A; Drimousis P; Markogiannakis H; Larentzakis A; Kofinas G; Misthos P; Filis K; Theodorou D
    Hellenic J Cardiol; 2009; 50(3):185-92. PubMed ID: 19465359
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Therapy of acute decompensated heart failure with levosimendan].
    Müller K; Peters A; Zeus T; Hennersdorf M; Strauer BE
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():119-22. PubMed ID: 16802535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single-centred experience with levosimendan in paediatric decompensated dilated cardiomyopathy.
    Séguéla PE; Mauriat P; Mouton JB; Tafer N; Assy J; Poncelet G; Nubret K; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2015; 108(6-7):347-55. PubMed ID: 25863426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levosimendan increases bleeding risk after heart valve surgery: a retrospective analysis of a randomized trial.
    Lahtinen P; Pitkänen O; Musialowicz T
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1238-42. PubMed ID: 25281042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levosimendan and calcium sensitization of the contractile proteins in cardiac muscle: impact on heart failure.
    Kota B; Prasad AS; Economides C; Singh BN
    J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):269-78. PubMed ID: 19087950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myocardial efficiency during levosimendan infusion in congestive heart failure.
    Ukkonen H; Saraste M; Akkila J; Knuuti J; Karanko M; Iida H; Lehikoinen P; Någren K; Lehtonen L; Voipio-Pulkki LM
    Clin Pharmacol Ther; 2000 Nov; 68(5):522-31. PubMed ID: 11103755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A systematic review on levosimendan in paediatric patients.
    Silvetti S; Silvani P; Azzolini ML; Dossi R; Landoni G; Zangrillo A
    Curr Vasc Pharmacol; 2015; 13(1):128-33. PubMed ID: 25440597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial.
    Wang A; Cui C; Fan Y; Zi J; Zhang J; Wang G; Wang F; Wang J; Tan Q
    Crit Care; 2019 Dec; 23(1):428. PubMed ID: 31888711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Levosimendan Use Increases Cardiac Performance after Coronary Artery Bypass Grafting in End-Stage Renal Disease Patients.
    Atalay H; Temizturk Z; Altinsoy HB; Azboy D; Colak S; Atalay A; Dogan OF
    Heart Surg Forum; 2016 Oct; 19(5):E230-E236. PubMed ID: 27801303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Levosimendan: right for the right ventricle?
    Lambermont B; Ghuysen A; Harstein G; D'Orio V
    Crit Care Med; 2007 Aug; 35(8):1995-6. PubMed ID: 17667254
    [No Abstract]   [Full Text] [Related]  

  • 57. Cost-benefits of incorporating levosimendan into cardiac surgery practice: German base case.
    Mardiguian S; Kivikko M; Heringlake M; Smare C; Bertranou E; Apajasalo M; Pollesello P
    J Med Econ; 2016; 19(5):506-14. PubMed ID: 26707159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral levosimendan in patients with severe chronic heart failure --the PERSIST study.
    Nieminen MS; Cleland JG; Eha J; Belenkov Y; Kivikko M; Põder P; Sarapohja T
    Eur J Heart Fail; 2008 Dec; 10(12):1246-54. PubMed ID: 18945637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
    Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
    Wang L; Cui L; Wei JP; Li GP; Qi GX; Hao YM; Wang WZ; Li HM; Liu J; Jiang DJ; Zhang YD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun; 38(6):527-30. PubMed ID: 21033135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.